Featured Research

from universities, journals, and other organizations

Researchers Estimate Significant Fatty Liver Disease In Children

Date:
October 2, 2006
Source:
University of California - San Diego
Summary:
Until now little was known about the prevalence of non-alcoholic fatty liver disease (NAFLD) in children. To gauge its occurrence a University of California, San Diego (UCSD) School of Medicine-led team studied 742 autopsy reports and tissue analysis of San Diego County children aged two to 19 who died from traumatic accidents, homicide or suicide and had a medical examiner autopsy between 1993 and 2003.

Until now little was known about the prevalence of non-alcoholic fatty liver disease (NAFLD) in children. To gauge its occurrence a University of California, San Diego (UCSD) School of Medicine-led team studied 742 autopsy reports and tissue analysis of San Diego County children aged two to 19 who died from traumatic accidents, homicide or suicide and had a medical examiner autopsy between 1993 and 2003.

Related Articles


The study, published in the October issue of Pediatrics, found that fatty liver was present in 13% of the children and adolescents whose records were studied. Utilizing rigorous standardization methods that narrowed the study population to represent children in the community, and adjusted for age, gender, race and ethnicity, the team estimated that NAFLD is present in 9.6% of the children and adolescents living in San Diego County. The team determined it was the most common cause of liver disease in the children and adolescents they studied.

NAFLD is defined by an accumulation of fat in the liver cells. The conclusions are significant because the disease can lead to cirrhosis of the liver, end-stage liver disease requiring a liver transplant, and liver cancer. The team found that in 23% of those children with fatty liver, the liver injury was severe enough to produce steatohepatitis, an inflammation caused by fat buildup in the liver. Over time steatohepatitis can cause progressive liver damage and has important implications for the long term health of children and young adults.

"Fatty liver disease is a very common problem that has gone largely unnoticed," said Jeffrey Schwimmer, UCSD Associate Professor of Pediatrics and Director of the Fatty Liver and Weight and Wellness Clinics at Rady Children's Hospital, who led the study. "If the prevalence in the United States is similar to the prevalence in San Diego, this would translate to 6.5 million children. The scale of the problem has enormous ramifications for the future health of these children."

Schwimmer and the research team presented several key findings. They discovered that the major risk factors for fatty liver in children are:

  • Age: They found that fatty liver prevalence increased with age, ranging from 0.7% in children 2-4 years of age, up to 17.3% for ages 15-19.
  • Ethnicity: The researchers found that the Hispanic Americans were at a particularly high risk with an 11.8% rate of fatty liver.
  • Gender: Boys had a much higher rate of fatty liver than girls.
  • Obesity: Overweight and obese children accounted for 81% of all cases of fatty liver.

The study was the first to provide a population estimate of the disease prevalence in children and was the first to use tissue analysis to determine the incidence of the disease within a given population, either pediatric or adult. The group found fatty liver disease in 11.8% of the Hispanics, 10.2% of the Asians, 8.6% of the Caucasian and 1.5% of the African American children. As the children's weight rose so did the incidence of fatty liver. The overweight and obese children accounted for 81% of the fatty liver cases.

The researchers noted that fatty liver disease is most prevalent among children and adolescents of Hispanic origin adding that the odds of a Hispanic child having fatty liver disease is five times higher than that for a black child. Within the Asian group the researchers noted there was a substantial variance among subgroups of Asian children. For example, fatty liver was found in 20% of the Filipino-American children but in only four percent of the Cambodian and Vietnamese children. Schwimmer said the most surprising finding was learning that nearly 20% of the children with fatty liver were in the healthy weight range. Children with healthy weights are unlikely to ever be screened for NAFLD and would be missed.

Previous estimates of fatty liver disease in U.S. children ranged from 0-3%. Schwimmer stated that fatty liver disease is usually diagnosed through biopsy tissue samples and that presented the first obstacle of determining the rate of the disease in a pediatric population. Children do not normally undergo liver tissue sampling; hence, until now, physicians and researchers did not have real data on how many children suffer from fatty liver. No one knew its actual occurrence. In order to study the prevalence of the disease Schwimmer said an autopsy study design was the only means the group had to assess NAFLD in the general population. The group chose to study autopsy reports in San Diego County because of its size as the fourth largest county in the United States and its significant racial and ethnic diversity. The racial and ethnic composition of the children studied closely emulated that of San Diego County's children as established by the 2000 U.S. census.

The group believes that genetics play a major role in the development of fatty liver disease. They are currently studying genes and dietary factors that may contribute to the disease's development and progression. Knowledge of the risk factors should help doctors develop a better understanding of why some children develop the disease; knowledge that could guide targeted therapies.

The study was funded by grants from the Rest Haven Foundation and the National Center for Research Resources of the National Institutes of Health for the General Clinical Research Center at UCSD.

The research team consisted of Schwimmer, Reena Deutsch, Ph.D,. UCSD Department of Family and Preventive Medicine, Tanaz Kahen, M.D., UCSD Department of Pediatrics, Joel Lavine, M.D., Ph.D., UCSD Department of Pediatrics, Christina Stanley, M.D., Office of the Medical Examiner -- County of San Diego, and Cynthia Behling, M.D., UCSD Department of Pathology.


Story Source:

The above story is based on materials provided by University of California - San Diego. Note: Materials may be edited for content and length.


Cite This Page:

University of California - San Diego. "Researchers Estimate Significant Fatty Liver Disease In Children." ScienceDaily. ScienceDaily, 2 October 2006. <www.sciencedaily.com/releases/2006/10/061002063917.htm>.
University of California - San Diego. (2006, October 2). Researchers Estimate Significant Fatty Liver Disease In Children. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2006/10/061002063917.htm
University of California - San Diego. "Researchers Estimate Significant Fatty Liver Disease In Children." ScienceDaily. www.sciencedaily.com/releases/2006/10/061002063917.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Liberia Releases Last Ebola Patient, But Threat Remains

Liberia Releases Last Ebola Patient, But Threat Remains

Newsy (Mar. 5, 2015) Liberia&apos;s last Ebola patient has been released, and the country hasn&apos;t recorded a new case in a week. However, fears of another outbreak still exist. Video provided by Newsy
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins